RecruitingPhase 1 / Phase 2NCT07061574
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Los Angeles, CA · San Francisco, CA · New Haven, CT · +8 more sites